ResearcherState Key Laboratory for Chemistry and Molecular Engineering of Medicinal ResourcesNo recent work listed

Heng‐Shan Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6474-8323; OpenAlex author ID A5038903918. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2023: 1 paper

Papers 1

Ligustrazine-Derived Chalcones-Modified Platinum(IV) Complexes Intervene in Cisplatin Resistance in Pancreatic Cancer through Ferroptosis and Apoptosis. Last author DOI 10.1021/acs.jmedchem.3c00922 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Meng Wang · 1 shared paper, 2023 · strength 0.19
- Paper Ligustrazine-Derived Chalcones-Modified Platinum(IV) Complexes Intervene in Cisplatin Resistance in Pancreatic Cancer t… DOI 10.1021/acs.jmedchem.3c00922 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.